Pages that link to "Q33269787"
Jump to navigation
Jump to search
The following pages link to Quantitative membrane proteomics reveals new cellular targets of viral immune modulators (Q33269787):
Displayed 50 items.
- HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation (Q21089617) (← links)
- The great escape: viral strategies to counter BST-2/tetherin (Q21090506) (← links)
- The formation of cysteine-linked dimers of BST-2/tetherin is important for inhibition of HIV-1 virus release but not for sensitivity to Vpu (Q21245050) (← links)
- Evolutionary history and attenuation of myxoma virus on two continents (Q21558784) (← links)
- BST2/Tetherin enhances entry of human cytomegalovirus (Q21559401) (← links)
- Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2 (Q21559418) (← links)
- Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin (Q24294470) (← links)
- Structural basis of HIV-1 tethering to membranes by the BST-2/tetherin ectodomain (Q24306855) (← links)
- The UBAP1 subunit of ESCRT-I interacts with ubiquitin via a SOUBA domain (Q24306898) (← links)
- Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin (Q24318564) (← links)
- HIV-1 Vpu targets cell surface markers CD4 and BST-2 through distinct mechanisms (Q24619066) (← links)
- Differential effects of human immunodeficiency virus type 1 Vpu on the stability of BST-2/tetherin (Q24629504) (← links)
- BST-2/tetherin: a new component of the innate immune response to enveloped viruses (Q24630382) (← links)
- Antiviral inhibition of enveloped virus release by tetherin/BST-2: action and counteraction (Q24635271) (← links)
- Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism (Q24644811) (← links)
- Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus (Q24650331) (← links)
- The role of BST-2/Tetherin in host protection and disease manifestation (Q26752737) (← links)
- KSHV: pathways to tumorigenesis and persistent infection (Q27026000) (← links)
- Direct restriction of virus release and incorporation of the interferon-induced protein BST-2 into HIV-1 particles (Q27316022) (← links)
- Structural and functional studies on the extracellular domain of BST2/tetherin in reduced and oxidized conformations (Q27664759) (← links)
- Aberrant regulation of the BST2 (Tetherin) promoter enhances cell proliferation and apoptosis evasion in high grade breast cancer cells (Q28384647) (← links)
- Application of proteomics to soft tissue sarcomas (Q28385995) (← links)
- Haploid genetic screens identify an essential role for PLP2 in the downregulation of novel plasma membrane targets by viral E3 ubiquitin ligases (Q28535346) (← links)
- Interferon-induced tetherin restricts vesicular stomatitis virus release in neurons (Q28585561) (← links)
- HSV-2 glycoprotein gD targets the CC domain of tetherin and promotes tetherin degradation via lysosomal pathway (Q28595739) (← links)
- Counteraction of the multifunctional restriction factor tetherin (Q28659945) (← links)
- Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu (Q29547836) (← links)
- The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein (Q29619540) (← links)
- Remodeling of endothelial adherens junctions by Kaposi's sarcoma-associated herpesvirus (Q30439948) (← links)
- BclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infection (Q30519179) (← links)
- Membrane-Associated RING-CH proteins associate with Bap31 and target CD81 and CD44 to lysosomes (Q30993115) (← links)
- Ultra structural characterisation of tetherin - a protein capable of preventing viral release from the plasma membrane (Q31034125) (← links)
- Endothelial cells support persistent gammaherpesvirus 68 infection (Q33369078) (← links)
- Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants (Q33408799) (← links)
- Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion (Q33450556) (← links)
- Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking (Q33455505) (← links)
- CAML does not modulate tetherin-mediated restriction of HIV-1 particle release (Q33528976) (← links)
- The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin (Q33564429) (← links)
- Characterization of E3 ligases involved in lysosomal sorting of the HIV-1 restriction factor BST2. (Q33743176) (← links)
- Antiviral activity of the interferon-induced cellular protein BST-2/tetherin (Q33807551) (← links)
- BST-2/tetherin-mediated restriction of chikungunya (CHIKV) VLP budding is counteracted by CHIKV non-structural protein 1 (nsP1) (Q33861091) (← links)
- Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins block distinct steps in transendothelial migration of effector memory CD4+ T cells by targeting different endothelial proteins. (Q33882749) (← links)
- Tetherin inhibits HIV-1 release by directly tethering virions to cells (Q34019962) (← links)
- The Vpu protein: new concepts in virus release and CD4 down-modulation (Q34021500) (← links)
- Kaposi's sarcoma-associated herpesvirus K3 and K5 ubiquitin E3 ligases have stage-specific immune evasion roles during lytic replication (Q34059252) (← links)
- Plasma membrane proteomics and its application in clinical cancer biomarker discovery (Q34122107) (← links)
- Viral hijacking of the host ubiquitin system to evade interferon responses (Q34130663) (← links)
- Influenza A virus does not encode a tetherin antagonist with Vpu-like activity and induces IFN-dependent tetherin expression in infected cells (Q34405097) (← links)
- The interferon-inducible host factor bone marrow stromal antigen 2/tetherin restricts virion release, but is it actually a viral restriction factor? (Q34492477) (← links)
- The Promise of Proteomics in the Study of Oncogenic Viruses (Q34549700) (← links)